TrialGynecologic oncology2009

A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer.

Kathleen M Schmeler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.